Design, Synthesis, and Mechanism of Dihydroartemisinin–Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents
Cancer patients frequently suffer from cancer-related fatigue (CRF), which is a complex syndrome associated with weakness and depressed mood. Neuroinflammation is one of the major inducers of CRF. The aim of this study is to find a potential agent not only on the treatment of cancer, but also for re...
Main Authors: | Haonan Yu, Zhuang Hou, Xiaoguang Yang, Yanhua Mou, Chun Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/9/1672 |
Similar Items
-
Design, Synthesis and Cytotoxicity of Novel Dihydroartemisinin-Coumarin Hybrids via Click Chemistry
by: Ye Tian, et al.
Published: (2016-06-01) -
Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
by: Li Q, et al.
Published: (2021-04-01) -
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents
by: Ran An, et al.
Published: (2018-09-01) -
TMT-based proteomics analysis of the anti-hepatocellular carcinoma effect of combined dihydroartemisinin and sorafenib
by: Chunying Hou, et al.
Published: (2020-06-01) -
Synthesis and Cytotoxicity of Novel 10-Substituted Dihydroartemisinin Derivatives Containing N-Arylphenyl-ethenesulfonamide Groups
by: Ping Gong, et al.
Published: (2013-03-01)